From there, demand is likely to weaken as the United States faces a wall of people hesitant to get the vaccine, the researchers said.
Officials and health experts have focused on combating the fluctuation of this vaccine, reaching 70% to 85% of the total population who need to be immunized against the virus – through vaccination or previous infection ̵
With more options identified around the world, such as the one that sends cases to India swiftly, staff are on watch to encourage Americans to reach that level of immunity before developing vaccine-resistant options and reaching the United States.
And looking at a variant of the B.1.617 virus in India, researchers are even more aware that under certain circumstances, virus transmission can increase “quickly and explosively,” the IHME notes.
Incentives and requirements could help, the study found
Incentives, amenities and requirements – such as cash, workplace clinics and mandatory pre-trip photos or big events – could be effective ways to encourage more people to get vaccinated, according to data released Thursday by the Kaiser Family Foundation.
Three out of 10 adults who do not want to be vaccinated immediately – including nearly half of those who want to “wait and see” – say they are more likely to be vaccinated if they are offered somewhere they normally go. for health care or if they need only one dose, according to a survey conducted from April 15 to 29 and including 2,097 adults in the United States.
Other reasons why people are more likely to get vaccinated are whether it is necessary to fly a plane, travel abroad or attend large gatherings such as sporting events. At least a quarter of people who are not ready to get the vaccine right away say that these reasons will make them more likely to be vaccinated.
More than a quarter, who were not ready to be vaccinated immediately, said their employers offering benefits such as paid vaccine leave and reimbursement and financial incentives would make inoculation more attractive.
And while the United States is preparing for the expected emergency use of Pfizer / BioNTech’s Covid-19 vaccine for use from 12 to 15 years of age next week, the Kaiser Family Foundation also found that 19% of parents said they definitely won “to vaccinate their children.
KFF notes that “parents’ intentions to vaccinate their children against Covid-19 are largely in line with their own experience and vaccination intentions.”
Reopening and relaxing measures
With declining demand for vaccines and reported cases, many employees are reducing their large-scale efforts to prevent the spread of the virus.
The Missouri National Guard has begun reducing its involvement in mass vaccination sites across the state of Shaw-Me, Gov. Mike Parson said Thursday.
“In the beginning, the demand for vaccines significantly exceeded the supply of vaccines. Now we see the opposite and the need for large-scale vaccination events has decreased,” Parson said. “Missouri is in a good position on the vaccine front, and this is largely due to the tireless efforts of members of our National Guard to bring vaccines into Missouri’s arms.”
In Minnesota, meanwhile, Gov. Tim Waltz announced a timetable for ending Covid-19 restrictions, including the state mask mandate.
Walz announced a three-step plan to end most restrictions, starting with lifting restrictions on outdoor collection on Friday at noon, all capacity limits and indoor and outdoor distance requirements on May 28, and the state mask mandate by July 1, or when 70% of Minnesotans aged 16 and older have been vaccinated.
“So our way forward is pretty clear. Minnesota now, for the next three weeks, it’s up to you to get the vaccines,” Waltz said. “It’s up to you to talk to your neighbors. It’s up to you to talk to your doctors. We have them available. They’re there. Anyone who gets that pushes us even harder.”
Boosters may be needed to take options
Getting starting doses may not be the end of the battle against Covid-19, as vaccine officials say a booster may be needed next year.
“We know that there is a raging pandemic, that there will be reinfections at some point, and the best way to ensure that we do not have renewed outbreaks in well-vaccinated countries is to raise and maintain the highest possible levels of immune neutralization.” Dr Stephen Hoge, president of the pharmaceutical company Moderna, said during a call for profit on Thursday.
Moderna said Wednesday that an intensified shot of her vaccine boosts the immune response against two alarming variants of the coronavirus: variant B.1.351, first seen in South Africa, and variant P.1, first seen in Brazil.
The declining immune response in people naturally infected with the virus also suggests a potential need for boosters, Ozlem Tureci, co-founder and chief medical officer of BioNTech, told CNN.
“Naturally infected people in these people have indications of a declining immune response,” Tureci said on Thursday. “So one might expect that immunized people will also have a declining immune response at some point and will need boosters.”
There are already six months of follow-up data on the Pfizer / BioNTech vaccine, which show that it is still 90% effective in preventing symptomatic disease, Turkey said, adding that they will continue to monitor this to find out more about time and frequency. of boosters.
“The good news is that mRNA technology allows frequent boosters,” she said.
CNN’s Lauren Mascarenhas, Naomi Thomas, Keith Allen, Chris Boyet and Jacqueline Howard contributed to the report.